1.29
4.44%
-0.06
Handel nachbörslich:
1.27
-0.02
-1.55%
Finanzdaten der Dermata Therapeutics Inc-Aktie (DRMA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
100.00%
-
|
-0.1614 | 0.0928 | 0.0311 | 0.0375 |
Operating Expenses
|
44.32%
3.2036
|
2.2198 | 1.812 | 1.7324 | 2.2777 |
Operating Income/Loss |
44.32%
-3.2036
|
-2.2198 | -1.812 | -1.7324 | -2.2777 |
Income/Loss From Continuing Operations Before Tax |
246.87%
3.1343
|
-2.134 | 0.0928 | -1.7014 | -2.2401 |
Income/Loss From Continuing Operations After Tax |
246.87%
3.1343
|
-2.134 | -1.7192 | -1.7014 | -2.2401 |
Net Income/Loss
|
246.87%
3.1343
|
-2.134 | -1.7192 | -1.7014 | 2.2401 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
6.2685
|
- | - | - | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):